Skip NavigationSkip to Content

Severe congenital neutropenia resulting from G6PC3 deficiency with increased neutrophil CXCR4 expression and myelokathexis

  1. Author:
    McDermott, D. H.
    De Ravin, S. S.
    Jun, H. S.
    Liu, Q. A.
    Priel, D. A. L.
    Noel, P.
    Takemoto, C. M.
    Ojode, T.
    Paul, S. M.
    Dunsmore, K. P.
    Hilligoss, D.
    Marquesen, M.
    Ulrick, J.
    Kuhns, D. B.
    Chou, J. Y.
    Malech, H. L.
    Murphy, P. M.
  2. Author Address

    [McDermott, David H.; Liu, Qian; Ojode, Teresa; Murphy, Philip M.] NIAID, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA. [De Ravin, Suk See; Hilligoss, Dianne; Marquesen, Martha; Ulrick, Jean; Malech, Harry L.] NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA. [Jun, Hyun Sik; Chou, Janice Y.] NICHHD, Sect Cellular Differentiat, NIH, Bethesda, MD 20892 USA. [Priel, Debra A. Long; Kuhns, Douglas B.] NCI, Clin Serv Program, SAIC Frederick Inc, Frederick, MD 21701 USA. [Noel, Pierre] NIH, Dept Lab Med, Ctr Clin, Bethesda, MD 20892 USA. [Takemoto, Clifford M.] Johns Hopkins Univ, Sch Med, Div Pediat Hematol, Baltimore, MD USA. [Paul, Scott M.] NIH, Dept Phys Med & Rehabil, Ctr Clin, Bethesda, MD 20892 USA. [Dunsmore, Kimberly P.] Univ Virginia, Hlth Sci Ctr, Div Hematol Oncol, Dept Pediat, Charlottesville, VA USA.;McDermott, DH, NIAID, Lab Mol Immunol, NIH, Bldg 10,Rm 11N107, Bethesda, MD 20892 USA.;dmcdermott@niaid.nih.gov
    1. Year: 2010
    2. Date: Oct
  1. Journal: Blood
    1. 116
    2. 15
    3. Pages: 2793-2802
  2. Type of Article: Article
  3. ISSN: 0006-4971
  1. Abstract:

    Mutations in more than 15 genes are now known to cause severe congenital neutropenia (SCN); however, the pathologic mechanisms of most genetic defects are not fully defined. Deficiency of G6PC3, a glucose-6-phosphatase, causes a rare multisystem syndrome with SCN first described in 2009. We identified a family with 2 children with homozygous G6PC3 G260R mutations, a loss of enzymatic function, and typical syndrome features with the exception that their bone marrow biopsy pathology revealed abundant neutrophils consistent with myelokathexis. This pathologic finding is a hallmark of another type of SCN, WHIM syndrome, which is caused by gain-of-function mutations in CXCR4, a chemokine receptor and known neutrophil bone marrow retention factor. We found markedly increased CXCR4 expression on neutrophils from both our G6PC3-deficient patients and G6pc3(-/-) mice. In both patients, granulocyte colony-stimulating factor treatment normalized CXCR4 expression and neutrophil counts. In G6pc3(-/-) mice, the specific CXCR4 antagonist AMD3100 rapidly reversed neutropenia. Thus, myelokathexis associated with abnormally high neutrophil CXCR4 expression may contribute to neutropenia in G6PC3 deficiency and responds well to granulocyte colony-stimulating factor. (Blood.2010;116(15):2793-2802)

    See More

External Sources

  1. DOI: 10.1182/blood-2010-01-265942
  2. WOS: 000282956700028

Library Notes

  1. Fiscal Year: FY2010-2011
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel